The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics
2008

The SU.FOL.OM3 Study: Testing B-vitamins and Omega-3 for Heart Health

Sample size: 2501 publication Evidence: moderate

Author Information

Author(s): Pilar Galan, Serge Briancon, Jacque Blacher, Sébastien Czernichow, Serge Hercberg

Primary Institution: UMR U557 Inserm, U1125 Inra, Cnam, Université Paris 13

Hypothesis

Does supplementation with folate, B-vitamins, and/or Omega-3 fatty acids reduce fatal and non-fatal cardiovascular events in patients with a history of cardiovascular diseases?

Conclusion

The study found that baseline characteristics of participants were comparable across all treatment groups.

Supporting Evidence

  • The study includes a large cohort of 2501 patients.
  • Participants have a history of cardiovascular events, making them a relevant population for the study.
  • The trial is designed to test the effects of nutritional doses of supplements.

Takeaway

This study is trying to see if taking certain vitamins and fish oil can help people who have had heart problems stay healthier.

Methodology

A randomized double-blind, placebo-controlled trial with a 2 × 2 factorial design over five years.

Potential Biases

Potential biases in participant selection and reporting of outcomes.

Limitations

The study may not account for interactions between B-vitamins and Omega-3 fatty acids in its sample size estimation.

Participant Demographics

Participants aged 45-80 with a history of myocardial infarction, unstable angina, or ischemic stroke; 1987 men and 514 women.

Digital Object Identifier (DOI)

10.1186/1745-6215-9-35

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication